Anatomic Neuroimaging Characteristics of Posterior Fossa Type A Ependymoma Subgroups.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
18
02
2021
accepted:
09
08
2021
pubmed:
23
10
2021
medline:
3
3
2022
entrez:
22
10
2021
Statut:
ppublish
Résumé
Posterior fossa type A (PFA) ependymomas have 2 molecular subgroups (PFA-1 and PFA-2) and 9 subtypes. Gene expression profiling suggests that PFA-1 and PFA-2 tumors have distinct developmental origins at different rostrocaudal levels of the brainstem. We, therefore, tested the hypothesis that PFA-1 and PFA-2 ependymomas have different anatomic MR imaging characteristics at presentation. Two neuroradiologists reviewed the preoperative MR imaging examinations of 122 patients with PFA ependymomas and identified several anatomic characteristics, including extension through the fourth ventricular foramina and encasement of major arteries and tumor type (midfloor, roof, or lateral). Deoxyribonucleic acid methylation profiling assigned ependymomas to PFA-1 or PFA-2. Information on PFA subtype from an earlier study was also available for a subset of tumors. Associations between imaging variables and subgroup or subtype were evaluated. No anatomic imaging variable was significantly associated with the PFA subgroup, but 5 PFA-2c subtype ependymomas in the cohort had a more circumscribed appearance and showed less tendency to extend through the fourth ventricular foramina or encase blood vessels, compared with other PFA subtypes. PFA-1 and PFA-2 ependymomas did not have different anatomic MR imaging characteristics, and these results do not support the hypothesis that they have distinct anatomic origins. PFA-2c ependymomas appear to have a more anatomically circumscribed MR imaging appearance than the other PFA subtypes; however, this needs to be confirmed in a larger study.
Sections du résumé
BACKGROUND AND PURPOSE
Posterior fossa type A (PFA) ependymomas have 2 molecular subgroups (PFA-1 and PFA-2) and 9 subtypes. Gene expression profiling suggests that PFA-1 and PFA-2 tumors have distinct developmental origins at different rostrocaudal levels of the brainstem. We, therefore, tested the hypothesis that PFA-1 and PFA-2 ependymomas have different anatomic MR imaging characteristics at presentation.
MATERIALS AND METHODS
Two neuroradiologists reviewed the preoperative MR imaging examinations of 122 patients with PFA ependymomas and identified several anatomic characteristics, including extension through the fourth ventricular foramina and encasement of major arteries and tumor type (midfloor, roof, or lateral). Deoxyribonucleic acid methylation profiling assigned ependymomas to PFA-1 or PFA-2. Information on PFA subtype from an earlier study was also available for a subset of tumors. Associations between imaging variables and subgroup or subtype were evaluated.
RESULTS
No anatomic imaging variable was significantly associated with the PFA subgroup, but 5 PFA-2c subtype ependymomas in the cohort had a more circumscribed appearance and showed less tendency to extend through the fourth ventricular foramina or encase blood vessels, compared with other PFA subtypes.
CONCLUSIONS
PFA-1 and PFA-2 ependymomas did not have different anatomic MR imaging characteristics, and these results do not support the hypothesis that they have distinct anatomic origins. PFA-2c ependymomas appear to have a more anatomically circumscribed MR imaging appearance than the other PFA subtypes; however, this needs to be confirmed in a larger study.
Identifiants
pubmed: 34674998
pii: ajnr.A7322
doi: 10.3174/ajnr.A7322
pmc: PMC8805767
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2245-2250Subventions
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Informations de copyright
© 2021 by American Journal of Neuroradiology.
Références
Pediatr Neurosurg. 2019;54(2):98-107
pubmed: 30699434
Front Oncol. 2020 Oct 02;10:558162
pubmed: 33117690
Neurosurgery. 1993 Jan;32(1):38-44
pubmed: 8421555
Neurol Clin. 2020 Feb;38(1):95-113
pubmed: 31761063
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96
pubmed: 33123732
Childs Nerv Syst. 2010 Dec;26(12):1765-72
pubmed: 20680298
J Clin Oncol. 2021 Mar 1;39(7):822-835
pubmed: 33405951
Acta Neuropathol. 2018 Aug;136(2):211-226
pubmed: 29909548
Cancer Cell. 2015 May 11;27(5):728-43
pubmed: 25965575
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Pediatr Neurosurg. 1996 Jun;24(6):299-305
pubmed: 8988495
Childs Nerv Syst. 2009 Oct;25(10):1229-40
pubmed: 19484252
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
J Neurosurg Pediatr. 2019 Oct 1;24(4):353-363
pubmed: 31574483
J Clin Neurosci. 2012 Sep;19(9):1228-35
pubmed: 22840355
Pediatr Neurol. 2020 Mar;104:3-12
pubmed: 31948735
Childs Nerv Syst. 2016 Aug;32(8):1441-7
pubmed: 27117266
Acta Neuropathol Commun. 2020 Oct 28;8(1):173
pubmed: 33115534
AJNR Am J Neuroradiol. 2019 Jan;40(1):154-161
pubmed: 30523141
AJNR Am J Neuroradiol. 2015 Dec;36(12):2386-93
pubmed: 26338912
Cancer Cell. 2011 Aug 16;20(2):143-57
pubmed: 21840481
Nature. 2010 Dec 23;468(7327):1095-9
pubmed: 21150899
World Neurosurg. 2020 Aug;140:e320-e327
pubmed: 32428725
Methods Mol Biol. 2003;226:33-4
pubmed: 12958476
AJNR Am J Neuroradiol. 2014 Jul;35(7):1263-9
pubmed: 24831600